Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional

Phase 2b/3 Study to Assess ABP-671 a Novel URAT1 Inhibitor in Participants With Gout

ClinicalTrials.gov ID: NCT05818085

Public ClinicalTrials.gov record NCT05818085. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 10:16 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-blind, Controlled, Phase 2b/3 Study to Assess the Efficacy and Safety of ABP-671 in Participants With Gout

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multicenter, randomized, double-blind, Phase 2b/3 study to evaluate the efficacy and safety of ABP-671. Part 1 of the study will compare the efficacy and safety of different doses and regimens of ABP-671 with placebo and allopurinol. Part 2 of the study will compare the dosing regimen(s) of ABP-671 selected from Part 1 with placebo in participants who have not been enrolled for Part 1.

Study identification

NCT ID
NCT05818085
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Atom Therapeutics Co., Ltd
Industry
Enrollment
300 participants

Conditions and interventions

Conditions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
19 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 11, 2023 (Actual)
Primary completion
Jan 30, 2025 (Actual)
Completion
Mar 30, 2025 (Actual)
Last update posted
Dec 22, 2025

2023 – 2025

United States locations

U.S. sites
35
U.S. states
17
U.S. cities
30
Facility City State ZIP Site status
Alliance for Multispecialty Research Tempe Arizona 85281 —
Tucson Neuroscience Research, LLC Tuscon Arizona 85710 —
Anaheim Clinical Trials (Cenexel ACT) Anaheim California 92801 —
Center for Clinical Trials of Sacramento Sacramento California 95823 —
Access Research Institute Brooksville Florida 34613 —
Nature Coast Clinical Reasearch Crystal River Florida 34429 —
JY Research Institute Inc. Cutler Bay Florida 33189 —
Accel Clinical Research Site DeLand Florida 32720 —
Jacksonville Center for Clinical Research Jacksonville Florida 32216 —
Accel Research Sites Network - St. Pete-Largo Clinical Research Unit Largo Florida 33777 —
A & D Doctor Center Miami Florida 33135 —
Bioclinical Research Alliance Miami Florida 33155 —
Cordova Research Institute Miami Florida 33155 —
Century Research LLC Miami Florida 33173 —
ITB Research Miami Florida 33173 —
Combined Research Orlando Phase I-IV Orlando Florida 32807 —
New Horizons Research Palmetto Bay Florida 33158 —
Advanced Clinical Research of Atlanta Atlanta Georgia 30309 —
Centricity Research Columbus Georgia 31904 —
Alliance for Multispecialty Research, LLC. Newton Kansas 67114 —
DelRicht Research New Orleans Louisiana 70115 —
AMR New Orleans Louisiana 70119 —
Annapolis Internal Medicine/CCT Research Annapolis Maryland 21401 —
DelRicht Research of Gulfport Gulfport Mississippi 39501 —
Quality Clinical Research, Inc Omaha Nebraska 68114 —
Santa Rosa Medical Center Las Vegas Nevada 89119 —
Inspire Santa Fe Medical Group Santa Fe New Mexico 87505 —
OnSite Clinical Solutions Salisbury North Carolina 28144 —
DelRicht Research Tulsa Oklahoma 74133 —
Altoona Center for Clinical Research Duncansville Pennsylvania 16635 —
ClinSearch Chattanooga Tennessee 37421 —
Medical Care/CCT Elizabethton Tennessee 37643 —
PanAmerican Clinical Research, LLC Brownsville Texas 78520 —
Quality Research Inc. San Antonio Texas 78209 —
Centricity Research Suffolk Virginia 23435 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05818085, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 22, 2025 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05818085 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →